Search Within

Daniel Diolaiti

Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Executive Committee, Center for Hematologic Malignancies (10)
  3. Pediatrics, Department of (10)
  4. Sarcoma Service (Pediatrics) (10)
  5. Stem Cell Transplantation and Cellular Therapy Service (10)
  6. Tow Center for Developmental Oncology (TCDO) (10)

More Groups

People
  1. Andrew Kung (10)
  2. Filemon Dela Cruz (10)
  3. Allison Rainey (6)
  4. Daoqi You (5)
  5. Armaan Siddiquee (4)
  6. Ervin Gaviria (4)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2019 (1)
  4. 2018 (4)
  5. 2016 (1)
Publications
  1. Cancer Discovery (2)
  2. Cancer Research (2)
  3. Cold Spring Harbor Molecular Case Studies (1)
  4. Genome Medicine (1)
  5. Journal of Clinical Oncology (1)
  6. Med (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (1)
  3. Biomed Central Ltd (1)
  4. Cell Press (1)
  5. Cold Spring Harbor Laboratory Press (1)
  6. Nature Publishing Group (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A transcripto me-based precision oncology platform for patient-therapy alignment in a diverse set of treatment-resistant malignancies
    Journal Article

    Mundi, P. S.; Dela Cruz, F. S.; Grunn, A.; Diolaiti, D.; Mauguen, A.; Rainey, A. R.; Guillan, K.; Siddiquee, A.; You, D.; Realubit, R.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting of the nuclear export protein XPO1 represents a non-genetically encoded vulnerability in malignant rhabdoid and Wilms tumors
    Meeting Abstract

    Coutinho, D. F.; Burke, C.; Mundi, P.; Ortiz, M. V.; Vallance, K. L.; Long, M.; Rosales, N.; Ibanez, G.; Marks, L. J.; Diolaiti, D.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
    Journal Article

    Coutinho, D. F.; Mundi, P. S.; Marks, L. J.; Burke, C.; Ortiz, M. V.; Diolaiti, D.; Bird, L.; Vallance, K. L.; Ibáñez, G.; You, D.; more...
    Med (2022)

    Fulltext@MSK | Save
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors
    Meeting Abstract

    Marks, L. J.; Diolaiti, D.; Mundi, P. S.; Gaviria, E.; Rainey, A.; Dela Cruz, F.; Califano, A.; Kung, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
    Journal Article

    Diolaiti, D.; Dela Cruz, F. S.; Gundem, G.; Bouvier, N.; Boulad, M.; Zhang, Y.; Chou, A. J.; Dunkel, I. J.; Sanghvi, R.; Shah, M.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors
    Meeting Abstract

    Marks, L.; Diolaiti, D.; Mundi, P.; Gaviria, E.; Rainey, A.; Dela Cruz, F.; Andrea, C.; Kung, A.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
    Journal Article

    Alvarez, M. J.; Subramaniam, P. S.; Tang, L. H.; Grunn, A.; Aburi, M.; Rieckhof, G.; Komissarova, E. V.; Hagan, E. A.; Bodei, L.; Clemons, P. A.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • A case study of an integrative genomic and experimental therapeutic approach for rare tumors: Identification of vulnerabilities in a pediatric poorly differentiated carcinoma
    Journal Article

    Dela Cruz, F. S.; Diolaiti, D.; Turk, A. T.; Rainey, A. R.; Ambesi-Impiombato, A.; Andrews, S. J.; Mansukhani, M. M.; Nagy, P. L.; Alvarez, M. J.; Califano, A.; more...
    Genome Medicine (2016)

    Fulltext@MSK | Save